If you are looking to buy stock in , it is important to know that as of April 28, 2026, the company no longer trades under its own ticker symbol. It was fully acquired by Jazz Pharmaceuticals in May 2021 for approximately $7.2 billion.
: The deal was designed to accelerate double-digit revenue growth. In the months following the close, Jazz reported that newly acquired products like Epidiolex contributed significantly to its total net product sales. Considerations Before Buying buy stock in gw pharmaceuticals
: The acquisition included GW’s cannabinoid product platform and clinical-stage programs for additional indications such as autism, schizophrenia, and multiple sclerosis-related spasticity. If you are looking to buy stock in
GW Pharmaceuticals pioneered the use of cannabis-derived medicines, most notably . Since the acquisition, this platform has become a cornerstone of the Jazz Pharmaceuticals business model. In the months following the close, Jazz reported